BOSTON, Nov 16 (Reuters) - Shares of Merck & Co Inc rose on Monday after results of a clinical trial of its cholesterol drug Zetia proved to be not as negative as some analysts had feared. Results of ...

NEW ORLEANS, November 8, 2004 – Results from a new study showed that coadministration of ZETIA® (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density ...

A new study raises more questions about ezetimibe (Zetia), a drug used by millions of Americans in tandem with statins to lower LDL, or "bad," cholesterol. The trial, known as ARBITER-6 HALTS, was ...

ORLANDO, Florida (Reuters) - The good news for Merck & Co's Zetia cholesterol fighter is that doctors do not seem unduly concerned about its latest setback in a clinical trial. The bad news is they ...

A new study casts some doubt on the benefits of Zetia, a cholesterol-lowering drug that about 1 million people in the U.S. use. The "Enhance" trial studied a combination of Zetia and the statin drug ...

WASHINGTON The House Committee on Energy and Commerce is investigating Merck and Schering-Plough for their handling of a critical clinical trial of Zetia, a cholesterol-lowering drug that the ...

Your doctor may recommend Zetia for kinds of high cholesterol. It’s a brand-name prescription drug that can be used in adults and some children. Specifically, Zetia can be used with a low cholesterol ...

Thirteen years after the fact, a copycat accord with Glenmark Pharmaceuticals has come back to haunt Merck & Co. And now, the alleged pay-for-delay collaborators must face a jury trial. Late last week ...

A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work. In ...

The FDA is evaluating the preliminary outcomes from an ongoing data review of Merck/Schering-Plough’s Vytorin (ezetimibe/simvastatin) and Zetia (ezetimibe), and Merck’s Zocor (simvastatin). The ...

Now that the findings of the Enhance study are out and show that the combination of Zetia and Zocor is no better than taking Zocor alone when it comes to a marker for atherosclerosis, what's it all ...